The gold market was a bit positive in the early hours of Wednesday, as the market continues to look for momentum to the upside. Ultimately, the market is bullish, but we have a noisy area to deal with.

Abercrombie & Fitch (ANF) underestimated itself when it came to tariffs. The company posted an earnings beat after initially telling customers to expect weakness.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=150548&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.

Allogene Therapeutics continues to advance its pipeline, with notable progress in key clinical trials and upcoming data readouts. The company's financial position remains stable, supported by a strong cash runway and prudent expense management. Key strengths include a differentiated allogeneic CAR-T platform and strategic partnerships, though clinical and regulatory risks remain significant.

LOS ANGELES , May 28, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Civitas Resources, Inc. ("Civitas" or "the Company") (NYSE: CIVI) for violations of the federal securities laws. Shareholders who purchased the Company's securities between February 27, 2024 and February 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 1, 2025.

ThredUp NASDAQ: TDUP is not a technology company per se, nor an AI-specific play, but it is a poster child representing what AI can do for a business. At face value, the lean into AI, including front- and back-of-house operations, has lifted the stock's price from penny stock territory, gaining roughly 1,000% in less than 12 months, and has it on track to double again in the coming quarters.

A peek into Berkshire Hathaway's top holdings reveals that Warren Buffett certainly has a liking for Apple's stock, comprising just over a quarter of its portfolio. It's easy to see why.

With the direction of interest rates in constant flux, a continuous go-to strategy for bond exposure is still short duration debt issues. That said, consider an active approach with the Neuberger Berman Short Duration Income ETF (NBSD).

Monro Muffler Brake (MNRO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.21 per share a year ago.

Abercrombie & Fitch (ANF) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $2.14 per share a year ago.

AIPI focuses on generating high income through covered call strategies, prioritizing yield over capital appreciation for investors seeking steady payouts. The ETF writes slightly out-of-the-money calls, enhancing income in flat or declining markets but capping upside in bullish conditions. AIPI targets AI-focused companies, balancing direct AI revenue leaders with key ecosystem enablers for diversified exposure.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=150549&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

The crude oil markets continue to see a lot of buyers on dips, and we have seen more of the same on Wednesday in the early hours of trading.

I'm buying the dip in IHS, targeting $8 by Q3 2025, driven by improving free cash flow and a compelling valuation discount. IHS has executed a successful turnaround: contract renegotiations, asset sales, balance sheet optimization, and strong cash flow growth position it for a breakout. Nigeria tax reforms, debt reduction, and long-term contracts underpin robust cash generation, enabling shareholder returns and reducing risk.

Candel Therapeutics Inc (NASDAQ:CADL) said on Wednesday the US Food and Drug Administration has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its lead immunotherapy candidate, CAN-2409, for the treatment of newly diagnosed localized prostate cancer in patients with intermediate- to high-risk disease. The RMAT designation is intended to expedite the development and review of regenerative therapies for serious conditions where preliminary evidence suggests the drug may address unmet medical needs.

Upgrading Marvell Technology, Inc. to Strong Buy with $114 price target, driven by robust data center demand and XPU ramp-up with AWS partnership. AI adoption and hyperscaler capital investments are fueling significant growth in cloud infrastructure, positioning Marvell for strong revenue acceleration in eFY26. The $2.5b sale of the automotive Ethernet business may help strengthen Marvell's balance sheet and sharpen its focus on high-growth data center opportunities.

LOS ANGELES , May 28, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Zenas Biopharma, Inc. ("Zenas" or "the Company") (NASDAQ: ZBIO) for violations of the federal securities laws. Shareholders who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025.

"So many stocks are going to move" on Nvidia's (NVDA) earnings, says Kevin Hincks. He urges investors to stay on their toes once the report drops.

BetMGM to donate meals to the Just One Project for every Aces home steal during the 2025 season Click here for high-res photo/video of The Fountains of Bellagio partnership launch LAS VEGAS , May 28, 2025 /PRNewswire/ -- BetMGM, a leading sports betting and iGaming operator, and the Las Vegas Aces announced today that BetMGM is the exclusive online casino and sportsbook partner of the WNBA's Las Vegas Aces. The agreement runs through the 2027 season, marking BetMGM's first major partnership with a women's professional sports franchise.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your UnitedHealth Group Incorporated (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unitedhealth-group-incorporated-lawsuit-submission-form?prid=150546&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.